Systematic review of fluorescence-guided surgery in pituitary neuroendocrine tumours [0.03%]
荧光引导手术在垂体神经内分泌肿瘤中的系统评价研究进展
Christopher Dillon Ovenden,Nicholas Candy,James McNeil et al.
Christopher Dillon Ovenden et al.
Objective: Fluorescence-guided surgery represents a potential novel technique to improve the extent of tumour resection, minimise resection of normal tissue, and optimise outcomes in pituitary neuroendocrine tumour surger...
68Ga-DOTA-TATE PET/CT improves accuracy and guides management in multiple endocrine neoplasia type 1 (MEN-1) patients with suspected duodeno-pancreatic neuroendocrine tumours [0.03%]
68镓-DOTA-TATE正电子发射断层扫描/X线计算机体层成像改善胰岛细胞肿瘤可疑的1型多发性内分泌瘤患者的诊断精确度和治疗方案
Kalyan Vamshi Vemulapalli,Kalyan Mansukhbhai Shekhda,Gowri Ratnayake et al.
Kalyan Vamshi Vemulapalli et al.
Purpose: To evaluate the added benefit and accuracy of 68Ga-DOTA-TATE PET/CT scans in detecting duodeno-pancreatic neuroendocrine tumours (dpNETs) compared to conventional cross-sectional imaging with CT or MRI scans in p...
Efficacy of systemic therapy in metastatic adrenocortical carcinoma: a meta-analysis of prospective clinical trials [0.03%]
转移性肾上腺皮质癌系统治疗疗效的Meta分析：前瞻性临床试验结果
S Shekar,A Hall,J Pham et al.
S Shekar et al.
Objective: To evaluate pooled prospective trial data investigating efficacy of systemic therapies in metastatic adrenocortical carcinoma (mACC), incorporating subgroup analyses by treatment modality and line, establishing...
Diagnostic characteristics, treatment outcomes, and prognostic factors in glucagonomas [0.03%]
胰高血糖素瘤的诊断特征、治疗结局和预后因素
Eleni Armeni,Alexander Branton,Juliana Porto et al.
Eleni Armeni et al.
Objective: Glucagonomas are rare islet cell tumours, accounting for 2% of such tumours, with an annual incidence of 0.01-0.1 per million. This study aimed to describe diagnostic characteristics and treatment outcomes in p...
FAK inhibition disrupts tumor growth, apoptosis, and transcriptional regulation in GI-NETs [0.03%]
FAK抑制可干扰胃肠道神经内分泌肿瘤的生长、凋亡和转录调节
Lara Toffoli,Angeliki Ditsiou,Luca Triboli et al.
Lara Toffoli et al.
Background: Gastrointestinal neuroendocrine tumors (GI-NETs) are rare neoplasms with limited therapeutic options and increasing clinical incidence. Focal adhesion kinase (FAK) has been implicated in oncogenic processes ac...
Survival and prognostic differences between appendiceal NETs and goblet cell adenocarcinomas [0.03%]
阑尾神经内分泌肿瘤与杯状细胞癌的生存及预后差异
Kim Dijke,José van den Berg,Koert F D Kuhlmann et al.
Kim Dijke et al.
Objective: Patients with appendiceal neuroendocrine tumours (aNETs) have an excellent prognosis. Appendiceal goblet cell adenocarcinomas (aGCAs), formerly called goblet carcinoid, show overlapping features with aNETs. Man...
Epidemiological insights and survival patterns in neuroendocrine neoplasia: a geographic perspective [0.03%]
神经内分泌肿瘤的流行病学见解和生存模式：地理视角透视
Jessica Mangion,Josanne Vassallo,Mark Gruppetta
Jessica Mangion
Neuroendocrine neoplasms, though rare, have shown marked increases in global incidence and prevalence over the past decade, as demonstrated by cancer registry data and studies from specialised tertiary centres. However, it remains unclear w...
Unmasking insulinoma following commencement of somatostatin analogues in malignant neuroendocrine tumours [0.03%]
生长抑素类似物治疗后的胰岛细胞瘤的诊断与治疗——2例类癌综合征患者的报告
Isuru Gamage,Emma Boehm,Gaurav Ghosh et al.
Isuru Gamage et al.
Objective: Somatostatin analogues (SSA) are used in the management of patients with metastatic gastroenteropancreatic neuroendocrine tumours (GEP-NET) to control hormone secretion and tumour growth. SSA can paradoxically ...
Gastric neuroendocrine neoplasms: analysis of a cohort of patients followed at the Brazilian National Cancer Institute [0.03%]
胃神经内分泌肿瘤：巴西国家癌症研究所随访的患者的队列分析
Sarah Adelaide M Campos,Bruno Vilhena Pereira,Cibele Barbosa Carroll et al.
Sarah Adelaide M Campos et al.
Objective: Gastric neuroendocrine neoplasms (G-NENs) are rare tumors categorized into subtypes, each exhibiting unique characteristics, levels of aggressiveness and prognostic implications. This study aimed to describe th...
A new link between insulinoma and congenital glucose-galactose malabsorption [0.03%]
新的胰岛素瘤与先天性葡萄糖半乳糖吸收不良之间的联系
Antonio Prinzi,Jelka Kuiper,Adorée M van der Wiel et al.
Antonio Prinzi et al.
Congenital glucose-galactose malabsorption (CGGM) is a rare autosomal recessive disorder caused by a biallelic mutation of solute carrier family 5 member 1 (SLC5A1), encoding the sodium-dependent glucose transport-1 (SGLT-1) protein. Patien...